Laser Capture Microdissection Market

Laser Capture Microdissection Market Study by Ultraviolet LCM, Infrared LCM, Ultraviolet & Infrared LCM, and Immunofluorescence LCM from 2024 to 2034

Analysis of Laser Capture Microdissection Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Laser Capture Microdissection Market Outlook (2024 to 2034)

Fact.MR, in its newly published study, says that the global laser capture microdissection market is pegged at US$ 177.5 million in 2024. The global market is forecasted to expand at a 10.1% CAGR and reach a market value of US$ 466.2 million by the end of 2034.

The laser capture microdissection (LCM) market is expected to experience growth opportunities in emerging economies, attributed to increasing research funding, particularly in the life sciences and medical fields, which plays a crucial role in driving the adoption of advanced technologies like laser capture microdissection. Adequate funding can have several positive impacts on the utilization and integration of laser-capture microdissection in research initiatives.

Adequate funding allows research institutions and laboratories to acquire high-quality systems, which addresses the initial barrier associated with the high upfront costs of purchasing and installing laser capture microdissection instruments.

Researchers, with sufficient funding, can access the latest models and versions of laser capture microdissection systems, ensuring that they benefit from advancements in precision, speed, and automation, which contribute to the overall quality and efficiency of research outcomes.

Research funding covers not only the acquisition of laser capture microdissection systems but also the ongoing operational costs, including consumables such as specialized slides and reagents, which ensure the continuous operation of the technology without financial constraints.

Report Attributes Details
Laser capture microdissection Market Size (2024E) US$ 177.5 million
Forecasted Market Value (2034F) US$ 466.2 million
Global Market Growth Rate (2024 to 2034) 10.1% CAGR
North America Market Share (2034F) 26.4%
Demand Growth in Japan (2024 to 2034) 11.5% CAGR
China Market Value (2034F) US$ 101.3 million
Demand for Ultraviolet LASER CAPTURE MICRODISSECTION (2034F) US$ 166.0 million
Revenue Share of Pharmaceutical and Biotech Companies Segment (2034F) 34.1%
Key Companies Profiled
  • Thermo Fisher Scientific, Inc.
  • Laxco
  • Danaher Corporation
  • Carl Zeiss AG
  • Molecular Machines & Industries
  • Theranostics Health Inc.
  • Ocimum Biosolutions LLC
  • 3DHISTECH Ltd.
  • GnomeDX
  • VitroVivo Biotech
  • Caresbio Laboratory LLC

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Which Market Trends are Opening New Opportunities for Manufacturers?

“Advancements in Technology to Fuel the Market Growth”

Advancements in optical technologies play a crucial role in improving precision. Higher-resolution imaging components, such as high-numerical aperture optics and advanced laser focusing systems, contribute to the ability to precisely isolate target cells or tissues.

Integration with advanced microscopy techniques allows researchers to visualize and select specific cells or structures with greater accuracy, which ensures that the laser captures only the intended biological material, minimizing contamination and improving overall precision.

Continuous improvements in laser technology enable the development of faster and more efficient laser capture microdissection systems. Faster lasers reduce the time required for sample collection, enhancing the overall speed of the process.

“Increasing Application in Research to Accelerate the Growth Prospects”

Laser capture microdissection facilitates the isolation of individual cells with high precision, which is particularly valuable in single-cell genomics, where researchers aim to analyze the genetic information of individual cells rather than bulk populations. It allows for the targeted collection of specific cells, providing insights into the genetic heterogeneity within tissues.

Researchers can use laser-captured microdissection to isolate cells from tissues of interest and extract genomic material for downstream applications like DNA sequencing, which is crucial for understanding the genetic makeup of specific cell types, identifying mutations, and exploring genomic variations associated with diseases.

Laser capture microdissection is employed to isolate cells or regions of tissues based on protein expression profiles, which enables researchers to focus on specific subsets of cells, allowing for more in-depth protein analysis. Proteomic studies benefit from the precision offered by laser capture microdissection, as it helps in obtaining enriched samples for targeted protein identification and quantification.

“Rising Incidence of Chronic Diseases to Contribute Significantly”

Cancer is characterized by significant heterogeneity, with diverse cell populations coexisting within a tumor. It allows researchers to isolate specific cells from tumors, enabling the study of their genetic and molecular profiles, which is crucial for understanding tumor heterogeneity, identifying driver mutations, and developing targeted therapies based on the unique characteristics of individual cancer cells.

The technology plays a pivotal role in cancer biomarker discovery. Researchers, by isolating cells with specific molecular features, can identify and characterize biomarkers associated with cancer progression, prognosis, and treatment response. The information is vital for the development of diagnostic tests and personalized treatment strategies.

Laser capture microdissection is valuable in preclinical studies for drug development. Isolating target cells from tumors allows researchers to assess drug responses at the cellular level, aiding in the identification of potential therapeutic targets and the evaluation of drug efficacy.

Which Factor is Restraining the Demand for Laser capture microdissection?

“High Initial Cost to Restrain the Market Growth”

Laser capture microdissection systems are highly specialized instruments designed for precision cell isolation. The technology involved, including advanced optics, laser systems, and automated stages, contributes to the elevated cost of these instruments.

Laser capture microdissection systems often consist of integrated components, such as high-resolution microscopy, automated sample handling, and advanced imaging software. The combination of these features enhances the precision and capabilities of the system but also adds to its overall cost.

Researchers, alongside the initial instrument cost, need to invest in specialized consumables such as laser capture microdissection-compatible slides, caps, and other accessories. The consumables are designed for compatibility with LCMs, contributing to ongoing operational costs.

Regular maintenance and service contracts are essential to ensuring the continued functionality and accuracy of laser capture microdissection systems. The contracts often come with additional costs, contributing to the overall financial commitment associated with the use of this technology.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

What Strategy Should Start-ups Incorporate to Enhance Their Market Presence?

“Growing Emphasis on Personalized Medicine is Key to Gaining Competitive Edge”

Laser capture microdissection allows researchers and clinicians to precisely isolate specific cells or tissues from a patient's sample, which is particularly valuable in the context of genomics, where understanding the genetic makeup of individual cells is essential for personalized medicine.

By isolating cells from specific regions, it facilitates the identification of genetic mutations associated with diseases, which is crucial for diagnosing genetic disorders, predicting disease risk, and selecting targeted therapies based on the individual's genomic profile.

The capability of laser capture microdissection to isolate individual cells renders it supportive in the burgeoning field of single-cell genomics. The approach provides insights into the genetic heterogeneity within tissues, allowing for a more comprehensive understanding of disease biology at the single-cell level.

The technology enables the isolation of cells based on their protein expression profiles, which is essential for proteomic analysis, where researchers aim to study the expression and function of proteins within specific cell populations.

Country-wise Insights

Fact.MR, a market research and competitive intelligence provider, asserts in its newly published study that North America is predicted to hold a 26.4% share of the global market by 2034.

There is potential for increased adoption of advanced technologies like laser capture microdissection for research and diagnostic purposes as healthcare infrastructure improves in emerging economies.

What is the Scenario of the Market in the United States?

“Advancements in Research and Development to Augment the Growth”

Attribute United States
Market Value (2024E) US$ 31.6 million
Growth Rate (2024 to 2034) 10.5% CAGR
Projected Value (2034F) US$ 86.0 million

The United States is predicted to account for 69.9% of the North American market by 2034. Ongoing advancements in biomedical and life sciences research, driven by substantial investments in R&D, create a demand for advanced technologies like laser capture microdissection.

The growing emphasis on precision medicine initiatives, where treatments are tailored to individual patients based on their unique genetic makeup, is likely to drive the laser capture microdissection market share for detailed molecular analysis.

The United States has a robust biotechnology and pharmaceutical industry, and these sectors extensively use laser capture microdissection in drug discovery, target validation, and biomarker discovery, contributing to market growth.

What is Projected to Propel Demand for Laser capture microdissection in China?

“Rising Incidence of Chronic Diseases in China to Fuel the Demand”

Attribute China
Market Value (2024E) US$ 34.6 million
Growth Rate (2024 to 2034) 11.3% CAGR
Projected Value (2034F) US$ 101.3 million

China is forecast to hold a 64.5% share of East Asia market revenue by 2034. The increasing prevalence of chronic diseases in China, including cancer and cardiovascular disorders, is expected to drive laser capture microdissection market growth for detailed molecular studies.

Collaborations between Chinese research institutions, universities, and international partners can facilitate knowledge exchange and technology transfer, leading to advancements in laser capture microdissection applications.

The integration of laser capture microdissection with genomics and proteomics technologies enhances its utility in comprehensive molecular analyses, aligning with the broader trends in global life sciences research.

What is projected to Propel Demand for Laser capture microdissection in Japan?

“Advanced Biomedical and Research Infrastructure to Enhance Market Prospects”

Attribute Japan
Market Value (2024E) US$ 13.9 million
Growth Rate (2024 to 2034) 11.5% CAGR
Projected Value (2034F) US$ 41.3 million

Japan is anticipated to hold a 26.3% share of East Asia market revenue by 2034. Japan has a well-established and advanced biomedical research infrastructure, with world-renowned research institutions and universities. The sophisticated research environment creates a demand for cutting-edge technologies such as laser capture microdissection.

Japan has a rapidly aging population, leading to a higher prevalence of aging-related diseases such as neurodegenerative disorders. The need for detailed molecular studies on specific cell types is expected to boost the laser-capture microdissection market.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Category-wise Insights

Based on the system, the global laser capture microdissection market is projected to rise significantly in the ultraviolet LCM segment.

UV laser systems are compatible with fluorescence techniques, enabling researchers to target and isolate specific cells labeled with fluorescent markers, which is particularly advantageous in applications such as fluorescence in situ hybridization (FISH) and immunofluorescence.

Which System to Contribute Significantly in the Sales of Laser capture microdissection?

“Ultraviolet LCM is expected to Accelerate the Demand for Laser capture microdissection”

Attribute Ultraviolet LCM
Segment Value (2024E) US$ 59.6 million
Growth Rate (2024 to 2034) 9.5% CAGR
Projected Value (2034F) US$ 159.0 million

The ultraviolet LCM segment is forecasted to hold 34.1% of the market share by 2034. UV laser capture microdissection systems often offer enhanced precision and spatial resolution. Researchers may prefer these systems for applications requiring high accuracy in isolating specific cells or tissue regions.

UV lasers are known for their ability to minimize heat generation during the microdissection process, which can be critical in preserving the integrity of delicate biological samples. Reduced tissue damage can lead to higher-quality isolated material for downstream analyses.

The UV laser capture microdissection systems are commonly used in genomics and proteomics applications, where the isolation of specific cells or regions for molecular analysis is crucial, which contributes to the increasing adoption of UV systems in these research areas.

Which End Users of Laser capture microdissection is Set to Occupy a Leading Market Share?

“Pharmaceutical and Biotech Companies Segment is Expected to be the Dominant End Users”

Attribute Pharmaceutical and Biotech Companies
Segment Value (2024E) US$ 59.1 million
Growth Rate (2024 to 2034) 8.4% CAGR
Projected Value (2034F) US$ 166.0 million

The pharmaceutical and biotech companies segment is predicted to occupy a 35.6% share of the global market by 2034. Pharmaceutical and biotech companies extensively use laser capture microdissection in drug discovery and development processes. The technique allows for the isolation of specific cells or tissue regions for molecular analysis, aiding in the identification of potential drug targets and understanding disease mechanisms.

Laser capture microdissection is valuable in target validation studies, where researchers aim to confirm the relevance of specific molecular targets for drug development. The precise isolation of cells using laser capture microdissection enhances the accuracy of these validation studies.

The increasing focus on precision medicine, where treatments are tailored to individual patients based on their molecular profiles, drives the laser capture microdissection market. Pharmaceutical and biotech companies utilize it to gather detailed molecular information from specific tissues for personalized treatment strategies.

Competitive Landscape

Key players in the laser capture microdissection industry are employing diverse strategies to achieve their goals. The approaches encompass the promotion of innovation, the implementation of stringent quality control measures for their product lines, the formation of strategic partnerships, the optimization of supply chain management systems, and the continuous enhancement of their products and technologies.

Recent Developments :

  • In 2023, Laxco introduced the Accuva Cellect Laser capture microdissection System. The cutting-edge system has been meticulously crafted to facilitate the precise isolation and capture of individual cells, offering unparalleled accuracy to elevate research and analysis standards. Distinguished by its innovative dual-laser LCM technology, the system effortlessly navigates through dense tissues and expansive areas in a singular pass.

Thermo Fisher Scientific Inc., Laxco, Danaher Corporation, Carl Zeiss AG, Molecular Machines & Industries, Theranostics Health Inc., Ocimum Biosolutions LLC, 3DHISTECH Ltd., GnomeDX, VitroVivo Biotech, and Caresbio Laboratory LLC are key players in the market.

Segmentation of Laser Capture Microdissection Market Research

  • By System :

    • Ultraviolet LCM
    • Infrared LCM
    • Ultraviolet and Infrared LCM
    • Immunofluorescence LCM
  • By End Users :

    • Contract Research Organizations
    • Pharmaceutical and Biotech Companies
    • Hospitals
    • Academic Institutes
  • By Region :

    • North America
    • Europe
    • East Asia
    • Latin America
    • Middle East & Africa
    • South Asia & Oceania

- FAQs -

What is the anticipated value of the Laser capture microdissection market in 2024?

The market is projected to reach a valuation of US$ 177.5 million in 2024.

What is the expected CAGR for the Laser capture microdissection market until 2034?

The laser capture microdissection industry is set to expand by a CAGR of 10.1% through 2034.

How much valuation is projected for the Laser capture microdissection market in 2034?

The laser capture microdissection market is forecast to reach US$ 466.2 million by 2034.

Which country is projected to lead the Laser capture microdissection market?

Japan is expected to be the top performing market, exhibiting a CAGR of 11.5% through 2034.

Which is the dominant system in the Laser capture microdissection domain?

Ultraviolet LCM is preferred, and are expected to account for a share of 35.6% in 2024.

- Also of Interest -

Ultrafast Laser Market

Ultrafast Laser Market By Type (Titanium-Sapphire, Fiber, Mode-Locked Dye), By Pulse Duration (Picosecond, Femtosecond), By End Use (Automotive, Industrial), By Application & By Region - Global Market Insights 2022-2032

Laser Diode Market

Laser Diode Market Report By Wavelength (Infrared, Ultraviolet, Visible), By Mode (Single Mode, Multi-Mode), By Application (Healthcare, Telecom, Manufacturing, Media and Entertainment) - Regional Forecast to 2028

Laser Capture Microdissection Market

Schedule a Call